Cancer BiologyeLifePeer-reviewed
Blocking SHP2 benefits FGFR2 inhibitor and overcomes its resistance in FGFR2-amplified gastric cancer
Yue Zhang, Hanbing Wang, Yutao Wei…·Yue Wang
This paper shows that blocking SHP2 enhances FGFR2 inhibitor effectiveness and overcomes resistance in FGFR2-amplified gastric cancer by inhibiting feedback pathways and boosting T cell immunity.
1 citation